≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Use of rivastigmine

Endpoint Browser

ADMED_ACHEI_RIVASTIGMINE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — N06DA03

1 out of 7 registries used, show all original rules.

5421

4. Check minimum number of events

Min. number of events 3
5421

5. Include endpoints

None

5421

6. Filter based on genotype QC (FinnGen only)

5421

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 5421 2665 2756
Unadjusted period prevalence (%) 1.06 0.91 1.21
Median age at first event (years) 78.83 79.32 78.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4316
Matched controls
43125
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.1
ICD-10 Finland
Alzheimer disease with late onset
14.3
323.0
2127
2741
N05AH04
ATC
quetiapine; oral
5.4
323.0
1251
3031
N06DX01
ATC
memantine; oral
15.2
323.0
2318
3054
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
10.2
323.0
983
1207
N06DA02
ATC
donepezil; oral
6.7
323.0
1343
2705
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
10.3
323.0
1179
1518
N06DA03
ATC
rivastigmine; oral, transdermal
+∞
323.0
4316
363
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
26.1
323.0
2402
1978
N05AX08
ATC
risperidone; systemic
6.2
323.0
1219
2587
P20
ICPC
Memory disturbance
5.2
323.0
1910
5732
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.9
299.5
740
1096
G20
ICD-10 Finland
Parkinson disease
8.3
270.2
644
893
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
8.5
255.6
596
794
G30.8
ICD-10 Finland
Other Alzheimer disease
8.3
251.1
596
816
P70
ICPC
Dementia
8.4
244.6
577
781
SPAT1053
SPAT
Memory test
3.2
240.4
1693
7197
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.2
233.2
1035
3009
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
8.7
183.5
418
525
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
27.4
182.1
254
98
G30.0
ICD-10 Finland
Alzheimer disease with early onset
14.9
172.5
297
213
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
7.0
168.6
445
698
G30
ICD-10 Finland
Alzheimer disease
9.9
165.7
348
378
N87
ICPC
Parkinsonism
11.4
154.6
301
282
F03
ICD-10 Finland
Unspecified dementia
3.5
135.6
711
2279
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
13.9
133.4
236
179
N06DA04
ATC
galantamine; oral
5.4
133.1
429
861
A28
ICPC
Limited function/disability NOS
2.4
129.7
1455
7524
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.7
123.0
607
1842
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
13.6
115.0
205
158
N06AB10
ATC
escitalopram; oral
2.9
112.4
797
3130
N06AX11
ATC
mirtazapine; oral
2.2
110.3
1552
8784
N04BD01
ATC
selegiline; oral
8.4
107.4
247
310
F0019, G301
ICD-10 Finland
NA
9.1
103.7
226
259
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
96.6
842
3708
R41.3
ICD-10 Finland
Other amnesia
4.4
90.7
351
847
SPAT1216
SPAT
Assessment of functional ability
2.2
87.9
1178
6385
R53
ICD-10 Finland
Malaise and fatigue
2.1
86.7
1308
7450
N05BA04
ATC
oxazepam; oral
2.0
81.2
1283
7408
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
68.9
76.6
88
13
N04BD02
ATC
rasagiline; oral
13.7
75.4
133
100
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
75.0
471
1675
SPAT1234
SPAT
Support of social functional capacity
2.8
70.9
513
1999
N02BE01
ATC
paracetamol; systemic, rectal
2.0
69.3
3616
30954
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
14.0
68.3
119
87
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
68.1
1757
11920
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
6.0
65.3
187
321
F06.7
ICD-10 Finland
Mild cognitive disorder
3.6
63.7
314
932
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
7.7
63.5
152
203
WYA20
NOMESCO Finland
Home visit
4.4
59.6
230
550
N04BC04
ATC
ropinirole; oral
8.4
59.1
134
164
TAB00
NOMESCO Finland
Lumbar puncture
4.7
58.9
208
455
AA1AD
NOMESCO Finland
CT of head and brain
1.8
58.5
1392
9076
193
Kela drug reimbursment
Rasagiline
13.1
57.7
103
80
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
57.5
994
5805
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
56.8
617
2967
A06AD11
ATC
lactulose; oral
1.8
53.5
1102
6814
F05.1
ICD-10 Finland
Delirium superimposed on dementia
6.3
48.5
133
216
N05AH03
ATC
olanzapine; systemic
3.7
48.5
225
635
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
47.6
998
6164
F009, G309
ICD-10 Finland
NA
7.2
47.5
118
167
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
44.2
307
1155
N06AB04
ATC
citalopram; systemic
1.8
43.2
919
5680
N06AX26
ATC
vortioxetine; oral
3.6
42.2
199
569
XA800
NOMESCO Finland
Neuropsychological investigation
4.4
41.4
157
369
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
41.0
1113
7388
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
40.6
327
1339
SPAT1254
SPAT
Administration of medicine
1.7
39.7
904
5686
130
Kela drug reimbursment
Malignant tumour
0.3
38.6
70
2476
N04BC05
ATC
pramipexole; oral
2.2
38.0
421
2021
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
38.0
335
1440
A04
ICPC
Weakness/tiredness general
1.8
36.5
732
4413
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
11.7
36.4
68
59
I95.1
ICD-10 Finland
Orthostatic hypotension
2.4
36.2
323
1395
N04BX02
ATC
entacapone; oral
8.7
36.2
79
92
S01.0
ICD-10 Finland
Open wound of scalp
2.1
36.2
428
2114
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.5
36.0
292
1199
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.2
34.6
377
1795
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
51.7
34.4
41
8
SPAT1229
SPAT
Assessment of need for aid
1.9
33.9
543
3023
N03AG01
ATC
valproic acid; systemic, rectal
2.7
33.6
243
933
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.9
33.3
517
2846
L28
ICPC
Limited function/disability (L)
1.6
32.1
978
6622
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
5.5
31.6
95
175
SPAT1304
SPAT
Counselling and guidance related to ageing
1.8
30.5
539
3099
SPAT1301
SPAT
No procedures
1.5
29.5
1449
10935
R55
ICD-10 Finland
Syncope and collapse
1.7
28.5
648
4029
F0009, G300
ICD-10 Finland
NA
7.9
28.3
65
83
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
28.1
520
8016
SPAT1101
SPAT
Orthostatic test
2.1
27.5
350
1776
J01DB01
ATC
cefalexin; oral
1.4
27.4
2965
25973
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.4
27.3
138
419
H02AB02
ATC
dexamethasone; systemic
0.3
26.2
73
2107
J01EA01
ATC
trimethoprim; systemic
1.5
26.2
1253
9350
R1250
NOMESCO Finland
Evaluation of functional capability
4.1
26.1
104
259
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.2
26.0
267
1235
F0014, G301
ICD-10 Finland
NA
10.7
26.0
50
47
F0029, G308
ICD-10 Finland
NA
9.7
25.6
52
54
N05AD01
ATC
haloperidol; systemic
2.5
25.6
208
854
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
25.0
805
5481
SPAT1360
SPAT
Extensive global examination
1.9
24.9
397
2195
U04
ICPC
Incontinence urine
2.1
24.6
306
1540
S72.0
ICD-10 Finland
Fracture of neck of femur
2.0
24.5
348
1843
Z75.5
ICD-10 Finland
Holiday relief care
3.4
24.0
119
357
SPAT1252
SPAT
Overall medication plan or its review
1.8
23.9
422
2414
F21
ICPC
NA
3.6
23.3
109
312
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.2
23.2
235
1081
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
22.9
1440
11263
A29
ICPC
General symptom/complaint other
1.7
22.7
539
3381
G04BD12
ATC
mirabegron; oral
1.7
22.5
521
3242
F00
ICD-10 Finland
Dementia in Alzheimer disease
6.3
22.2
59
94
J01CA08
ATC
pivmecillinam; oral
1.4
22.2
1566
12487
N04BC09
ATC
rotigotine; transdermal
9.3
22.2
46
50
N07AA06
ATC
NA
80.4
21.7
24
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
21.6
1589
12752
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
8.8
21.5
46
53
S06.0
ICD-10 Finland
Concussion
1.7
21.4
445
2681
R25.1
ICD-10 Finland
Tremor, unspecified
2.7
21.1
147
556
C10AA01
ATC
simvastatin; oral
1.4
21.0
2282
19499
H02AA02
ATC
fludrocortisone; oral
4.2
20.6
79
191
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
8.4
20.6
45
54
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
20.5
307
1660
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.0
20.5
123
422
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
20.2
603
4010
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
19.8
381
2239
Z29
ICPC
Social problem NOS
3.1
19.8
110
360
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
19.8
739
5179
SPAT1284
SPAT
Extensive health certificate
2.9
19.4
122
432
W19
ICD-10 Finland
Unspecified fall
1.7
19.3
444
2754
N02AA05
ATC
oxycodone; systemic
1.5
19.3
799
5727
S70.0
ICD-10 Finland
Contusion of hip
2.1
19.3
226
1108
SPAT1050
SPAT
Extensive neurological examination
2.6
18.8
136
525
N30.0
ICD-10 Finland
Acute cystitis
1.5
18.7
657
4538
N03AE01
ATC
clonazepam; systemic
2.0
18.3
226
1134
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
44.1
18.2
22
5
Z2445
NOMESCO Finland
Psychologist
3.4
17.9
86
254
F001, G301
ICD-10 Finland
NA
6.9
17.9
44
64
A04AA02
ATC
granisetron; systemic, transdermal
0.2
17.7
22
952
SPAT1251
SPAT
Organisation of medication
1.9
17.1
246
1309
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.2
17.0
12
734
F02.80
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without additional symptoms
50.1
17.0
20
*
R42
ICD-10 Finland
Dizziness and giddiness
1.4
16.8
1066
8256
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
16.6
840
6243
F0230, G20
ICD-10 Finland
NA
90.3
16.6
18
*
N28
ICPC
Limited function/disability (N)
2.9
16.5
100
346
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
16.5
268
4305
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
16.3
11
692
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
8.0
16.2
36
45
N06AB06
ATC
sertraline; oral
1.8
16.2
264
1471
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
16.1
1055
8206
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.7
16.0
490
6898
G04CA02
ATC
tamsulosin; oral
1.4
15.9
1201
9555
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
15.8
1748
14724
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
15.8
278
1587
A98
ICPC
Health maint/preventive medicine
1.3
15.4
3204
29448
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.6
15.2
196
3335
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
14.8
391
5668
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.0
14.8
87
298
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
2.6
14.7
104
399
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
14.5
247
1395
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
14.2
623
8264
KMAK
NOMESCO Finland
NA
1.3
14.2
1293
10549
R06.0
ICD-10 Finland
Dyspnoea
0.7
14.0
693
9021
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.4
14.0
120
513
P29
ICPC
Psychological sympt/compl other
2.6
13.7
101
396
SPAT1285
SPAT
Provision of consultation response
1.8
13.7
226
1265
N06AX16
ATC
venlafaxine; oral
1.7
13.6
265
1564
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
13.6
305
1874
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.9
13.3
209
1150
N29
ICPC
Neurological sympt/complt other
2.6
12.8
92
356
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
5.0
12.8
40
80
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.4
12.8
642
4742
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.1
12.7
8
528
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
12.7
379
2512
F0232, G20
ICD-10 Finland
NA
70.0
12.6
14
*
E0000UV
ATC
NA
1.3
12.5
1325
11000
F05.9
ICD-10 Finland
Delirium, unspecified
2.1
12.5
136
651
R44.1
ICD-10 Finland
Visual hallucinations
4.0
12.5
49
124
F01.2
ICD-10 Finland
Subcortical vascular dementia
3.7
12.5
54
149
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
12.4
207
1161
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.7
12.3
85
324
SPAT1139
SPAT
Nutrition survey
2.0
12.2
163
848
S00.0
ICD-10 Finland
Superficial injury of scalp
2.3
12.2
108
470
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
12.0
594
4371
XX3DW
NOMESCO Finland
Time consuming IT work
0.5
11.8
123
2215
N06AX21
ATC
duloxetine; oral
1.6
11.7
284
1789
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.0
11.5
144
728
D07AA02
ATC
hydrocortisone; topical
1.5
11.5
439
3070
F06.0
ICD-10 Finland
Organic hallucinosis
7.1
11.5
27
38
R11
ICD-10 Finland
Nausea and vomiting
1.6
11.4
343
2272
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.9
11.4
158
834
M04AA01
ATC
allopurinol; systemic
0.7
11.2
399
5497
N99
ICPC
Neurological disease other
3.0
11.1
61
202
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
11.0
638
4827
N04BC06
ATC
cabergoline; oral (dopamine agonists)
5.8
11.0
30
52
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
10.8
99
441
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
8.2
10.8
23
28
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.8
1074
8812
R03BB04
ATC
tiotropium bromide; inhalant
0.6
10.7
247
3687
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.5
10.6
410
2874
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
10.6
589
4425
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
10.5
19
668
N04BB01
ATC
amantadine; oral
2.7
10.5
68
252
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.0
10.1
125
633
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.0
1192
9988
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.8
10.0
162
907
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.6
9.9
148
2430
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.1
9.7
*
351
SPAT1153
SPAT
Removal of sutures
0.8
9.6
782
9585
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
55.1
9.6
11
*
XF606
NOMESCO Finland
Ortostatic test
3.1
9.5
49
157
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
9.5
1762
15502
C03DA01
ATC
spironolactone; oral
0.7
9.4
310
4338
F02.3
ICD-10 Finland
Dementia in Parkinson disease
100.2
9.4
10
*
F0022, G308
ICD-10 Finland
NA
17.5
9.4
14
8
SPAT1244
SPAT
Occupational therapy
2.8
9.4
59
214
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
5.6
9.3
26
47
F002, G308
ICD-10 Finland
NA
8.0
9.3
20
25
G04CB02
ATC
dutasteride; oral
1.5
9.2
314
2149
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
9.2
132
709
H02AB06
ATC
prednisolone; systemic
0.8
9.1
1353
15531
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
9.1
1187
10028
F0011, G301
ICD-10 Finland
NA
7.7
9.1
20
26
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
9.1
285
1913
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
11.5
9.0
16
14
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.9
9.0
133
721
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
9.0
5
355
R35
ICD-10 Finland
Polyuria
1.6
8.9
253
1660
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
4.3
8.9
31
72
359
Kela drug reimbursment
Mirabegroni
3.1
8.8
45
144
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.4
8.7
70
294
F0013, G301
ICD-10 Finland
NA
14.0
8.7
14
10
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
7.6
8.6
19
25
WX212
NOMESCO Finland
Femoral plexus blockade
2.0
8.6
107
546
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.7
8.5
56
212
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
20.0
8.5
12
6
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
6.4
8.5
21
33
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
2.8
8.4
52
189
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.4
8.4
26
709
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.4
8.3
38
889
N04AA02
ATC
biperiden; systemic
2.6
8.3
58
226
SPAT1104
SPAT
Monitoring of emergency patient
1.5
8.3
263
1769
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
1.9
8.3
119
640
N06BA04
ATC
methylphenidate; oral
10.7
8.3
15
14
N05AH02
ATC
clozapine; systemic
4.7
8.2
26
55
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
14.5
8.2
13
9
S01
ICD-10 Finland
Open wound of head
2.5
8.1
60
243
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.2
8.0
5
328
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.8
8.0
25
52
WX402
NOMESCO Finland
General anaesthesia
0.6
8.0
168
2558
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.4
8.0
39
890
R33
ICD-10 Finland
Retention of urine
1.4
8.0
418
3104
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
6.3
8.0
20
32
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.8
8.0
47
166
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
7.9
49
1031
G04BD08
ATC
solifenacin; oral
1.4
7.9
316
2234
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
7.9
127
712
SPAT1167
SPAT
Insertion of urinary catheter
1.6
7.9
195
1236
F0024, G308
ICD-10 Finland
NA
9.4
7.8
15
16
S72.1
ICD-10 Finland
Pertrochanteric fracture
1.7
7.8
160
968
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
0.0
7.7
*
191
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.7
1565
13811
G04BD10
ATC
darifenacin; oral
2.7
7.7
49
181
R32
ICD-10 Finland
Unspecified urinary incontinence
1.8
7.7
125
703
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.2
7.6
72
329
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
8.0
7.6
16
20
-2
ICPC
NA
2.5
7.6
54
215
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
7.5
182
1146
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
8.8
7.5
15
17
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
7.5
224
1488
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.6
7.5
165
2488
K59.0
ICD-10 Finland
Constipation
1.5
7.4
267
1847
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.6
7.4
105
1743
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
80.1
7.4
8
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.3
7.4
11
430
WZC30
NOMESCO Finland
Teaching
0.7
7.4
181
2669
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
0.6
7.3
82
1444
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
7.3
1039
8832
N06AX12
ATC
bupropion; oral
2.3
7.3
61
264
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
0.5
7.3
62
1176
R2110
NOMESCO Finland
Giving the first information
1.6
7.3
181
1153
WW500
NOMESCO Finland
Blood transfusion
0.5
7.2
47
972
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
7.9
7.1
15
19
LAITO
NOMESCO Finland
NA
5.0
7.1
21
42
N04BC02
ATC
pergolide; oral
6.0
7.1
18
30
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
0.5
7.0
58
1110
SPAT1262
SPAT
Handing over of treatment supplies
1.3
7.0
687
5590
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
0.3
7.0
14
465
A78
ICPC
Infectious disease other/NOS
2.7
7.0
45
167
SPAT1263
SPAT
Sampling
1.2
7.0
1506
13329
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.0
1478
13059
D12
ICPC
Constipation
1.7
6.9
150
919
AA1AA
NOMESCO Finland
Head X-ray examination
2.7
6.9
45
169
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.9
1269
11058
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
6.9
177
1135
L01BC06
ATC
capecitabine; oral
0.4
6.9
24
624
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
2.5
6.8
50
203
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
40.1
6.8
8
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
6.7
698
5719
R02
ICPC
Shortness of breath/dyspnoea
0.7
6.7
261
3551
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
2.0
6.7
83
425
A01
ICPC
Pain general/multiple sites
1.4
6.7
285
2045
R03AK07
ATC
formoterol and budesonide; inhalant
0.7
6.6
282
3785
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
0.8
6.6
629
7609
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
12.2
6.6
11
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
0.4
6.5
26
638
E86
ICD-10 Finland
Volume depletion
1.7
6.5
138
843
H25.8
ICD-10 Finland
Other senile cataract
0.8
6.5
438
5518
Z51.0
ICD-10 Finland
Radiotherapy session
0.1
6.5
*
245
A04AA01
ATC
ondansetron; systemic, rectal
0.6
6.5
71
1256
SPAT1014
SPAT
Treatment of eyes
1.9
6.5
92
496
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
1.9
6.5
90
482
R63.4
ICD-10 Finland
Abnormal weight loss
1.6
6.4
140
861
F0234, G20
ICD-10 Finland
NA
69.9
6.4
7
*
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.4
1138
9876
N30.9
ICD-10 Finland
Cystitis, unspecified
1.4
6.4
245
1721
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
6.4
493
6104
S18
ICPC
Laceration/cut
0.8
6.4
1139
12953
J01CA04
ATC
amoxicillin; systemic
1.2
6.3
2597
24225
U28
ICPC
Limited function/disability (U)
2.2
6.3
58
264
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
8.1
6.3
13
16
J96.1
ICD-10 Finland
Chronic respiratory failure
0.4
6.3
31
702
D01BA02
ATC
terbinafine; oral; topical
1.2
6.3
754
6278
L03AA13
ATC
pegfilgrastim; parenteral
0.4
6.3
20
536
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.3
6.2
54
238
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
6.2
180
2574
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.3
6.2
52
227
T03
ICPC
Loss of appetite
4.1
6.2
22
54
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
0.2
6.2
*
254
SPAT1111
SPAT
Planning of analgesia
2.2
6.2
57
261
T90.5
ICD-10 Finland
Sequelae of intracranial injury
2.9
6.2
34
118
I50.1
ICD-10 Finland
Left ventricular failure
0.7
6.1
134
2020
SPAT1059
SPAT
Spirometry at the office
0.5
6.1
63
1135
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
6.1
181
1204
SPAT1325
SPAT
Vaccination
1.2
6.1
1458
12982
L15
ICPC
Knee symptom/complaint
0.8
6.1
409
5158
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
10.0
6.0
11
11
WF002
NOMESCO Finland
Radical radiotherapy
0.5
6.0
55
1021

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
253
225
11.72
243.12
1.0
1.0
ng/l
53.6
42.7
2.31
185
133
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
253
225
11.72
243.12
1.0
1.0
ng/l
538.2
655.5
3.45
181
128
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
249
224
11.58
237.43
1.0
1.0
ng/l
388.4
318.2
2.20
184
134
(3019309) Folate [Moles/volume] in Red Blood Cells
2181
12346
2.28
177.01
1.9
1.9
nmol/l
1228.4
1162.2
2.69
1700
8963
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
295
692
4.44
114.55
1.2
1.3
mg/l
475.0
615.8
2.41
271
654
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
264
608
4.50
104.84
1.1
1.2
mmol/l
3.8
3.9
1.18
240
557
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
255
590
4.48
100.65
1.2
1.3
e6/l
21.8
26.8
0.11
202
468
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
255
590
4.48
100.65
1.3
1.4
e6/l
335.6
734.4
0.88
206
489
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1625
9918
1.91
93.95
2.9
3.1
mmol/l
2.5
2.5
14.02
1415
8439
(3044290) Cell count panel - Cerebral spinal fluid
227
540
4.33
86.37
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2228
16139
1.64
64.79
2.5
3.1
mmol/l
2.3
2.4
0.94
1901
13342
(3023410) Appearance of Cerebral spinal fluid
119
238
5.08
55.93
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2698
21000
1.56
54.65
2.4
2.2
pmol/l
90.8
92.2
0.85
1448
10679
(3031040) Bacteria [#/volume] in Urine by Automated count
3574
29716
1.59
53.59
6.4
5.9
e6/l
1941.0
2555.1
0.30
65
557
(3021960) Folate [Moles/volume] in Serum or Plasma
1798
12862
1.59
51.95
1.7
1.6
nmol/l
20.8
20.0
1.18
1567
10742
(3026008) Bacteria identified in Urine by Culture
2282
17550
1.51
45.98
3.9
3.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1563
11119
1.57
44.82
1.8
1.8
pmol/l
450.2
12756838.6
4.02
1278
8678
(3009466) Valproate [Moles/volume] in Serum or Plasma
149
443
3.42
41.25
3.0
3.5
umol/l
323.4
331.2
0.26
119
349
(3024561) Albumin [Mass/volume] in Serum or Plasma
2595
20912
1.46
39.07
3.6
4.3
g/l
34.7
33.9
11.33
2309
18952
(3019150) Specific gravity of Urine by Refractometry
1291
9306
1.50
33.01
6.1
5.2
kg/l
1.0
1.0
1.27
173
1603
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
952
6423
1.58
32.93
1.9
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
99
268
3.74
31.62
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
946
6459
1.56
30.86
1.9
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
660
4151
1.67
30.19
4.2
3.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
580
8840
0.61
26.63
1.5
1.6
mmol/l
1.2
1.3
0.60
480
7229
(3029937) Albumin [Presence] in Urine by Test strip
1459
11203
1.41
25.60
5.7
5.0
estimate
0.0
0.0
0.80
367
3461
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
534
3314
1.67
25.52
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1160
15171
0.70
24.82
2.1
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1942
15765
1.36
23.85
2.5
2.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1232
9326
1.41
23.07
1.9
1.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3248
28548
1.34
22.92
25.8
26.7
g/l
329.7
329.8
0.34
3145
28049
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1894
15421
1.35
22.45
5.6
5.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1303
10010
1.39
22.26
5.4
4.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
827
5860
1.48
21.96
10.2
9.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4121
37799
1.37
20.34
18.6
19.8
mg/l
31.5
28.4
5.64
3514
32029
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2556
21971
1.30
19.83
4.1
5.7
mmol/l
1.2
1.2
3.14
2256
19448
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
78
247
3.18
19.68
1.1
1.1
—
57.5
—
0
5
(3018418) pH of Serum or Plasma
1769
14485
1.32
19.45
2.9
3.8
ph
7.4
7.4
0.43
261
2699
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1773
14532
1.32
19.33
2.1
2.1
u/l
244.1
221.2
0.45
1617
13434
(1761868) Lipid panel - Serum or Plasma
579
8267
0.66
18.90
3.0
3.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
88
310
2.86
18.47
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3277
29275
1.30
18.26
5.4
5.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
79
264
3.01
18.22
1.1
1.1
—
2.3
—
0
7
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2787
24430
1.28
17.79
4.7
6.3
mmol/l
1.2
1.2
9.69
2280
20142
(3035350) Ketones [Presence] in Urine by Test strip
2357
20253
1.29
17.52
5.1
4.6
estimate
0.0
0.0
0.00
400
3717
(40761511) CBC panel - Blood by Automated count
4080
37640
1.33
17.40
17.6
19.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1114
14011
0.74
17.16
3.2
3.9
mg/mmol
7.5
10.1
1.47
678
8749
(3012516) Albumin [Mass/volume] in Urine
1043
13158
0.74
16.21
2.7
3.1
mg/l
402.1
368.6
0.08
663
8322
(3019550) Sodium [Moles/volume] in Serum or Plasma
4253
39594
1.33
16.17
22.5
24.1
mmol/l
139.8
139.4
18.12
4069
38300
(3023103) Potassium [Moles/volume] in Serum or Plasma
4255
39632
1.33
16.00
22.6
24.3
mmol/l
4.0
4.0
8.17
4063
38268
(3021601) Nitrite [Presence] in Urine by Test strip
2335
20222
1.27
15.66
6.4
6.2
estimate
0.0
0.0
0.00
383
3671
(3010813) Leukocytes [#/volume] in Blood
4277
39923
1.33
15.43
26.5
29.0
e9/l
7.1
7.2
1.20
4060
38184
(3009508) Creatinine [Moles/volume] in Urine
1055
13185
0.75
15.16
2.6
3.1
mmol/l
6.8
6.6
1.19
846
10570
(3026361) Erythrocytes [#/volume] in Blood
4273
39912
1.32
15.11
26.5
28.9
e12/l
4.2
4.3
3.29
4054
38169
(3009261) Glucose [Presence] in Urine by Test strip
2359
20515
1.26
15.07
5.1
4.7
estimate
0.0
0.0
0.50
390
3665
(3007461) Platelets [#/volume] in Blood
4272
39906
1.32
15.06
26.4
28.9
e9/l
236.1
237.1
0.45
4078
38355
(3000963) Hemoglobin [Mass/volume] in Blood
4273
39920
1.32
15.03
26.7
29.2
g/l
127.8
128.8
4.38
4106
38866
(3024731) MCV [Entitic volume]
4272
39911
1.32
15.01
26.4
28.9
fl
91.9
92.0
0.51
4105
38828
(3035941) MCH [Entitic mass]
4272
39911
1.32
15.01
26.4
28.8
pg
30.4
30.4
0.11
4103
38827
(3023368) Bacteria identified in Blood by Culture
1815
15305
1.28
14.98
3.7
4.2
—
—
—
0
0
(4035726)
209
3586
0.56
14.70
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
305
4745
0.62
14.56
1.2
1.2
u/ml
11.9
16.2
0.64
93
1515
(3026493) Urate [Moles/volume] in Serum or Plasma
860
11018
0.74
14.54
2.2
2.9
umol/l
6164.7
7921.3
0.51
689
8990
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2022
17334
1.26
14.39
2.1
2.2
nmol/l
78.4
80.4
2.59
1724
14654
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3120
28104
1.25
14.37
3.8
4.0
pmol/l
15.3
15.3
0.28
2723
24417
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
430
6157
0.67
13.86
2.5
3.4
u/l
247.4
250.0
0.12
372
5684
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
61
207
2.96
13.79
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2247
19613
1.24
13.32
4.4
4.7
ng/l
53.3
95.5
1.18
1759
15765
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3688
34110
1.25
12.30
4.9
5.0
mu/l
2.0
2.1
2.87
3268
29877
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
348
5041
0.67
11.81
1.2
1.2
iu/ml
56.1
41.5
0.65
107
1547
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3127
33798
0.82
11.40
4.0
4.6
mmol/l
1.5
1.4
2.09
2688
29396
(3017181) Myelocytes/100 leukocytes in Blood
219
3473
0.61
11.28
2.6
3.6
%
0.8
1.0
0.62
49
1094
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1658
19065
0.81
11.16
3.7
4.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
389
5452
0.69
11.07
2.6
3.6
ug/l
8.6
23.9
3.37
310
4550
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
49
169
2.91
10.84
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
208
3300
0.61
10.74
2.6
3.6
%
0.1
0.1
0.33
46
1019
(3006504) Eosinophils/100 leukocytes in Blood
1612
18482
0.82
10.29
4.2
5.4
%
2.8
2.8
0.29
1420
16804
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3027
32671
0.83
10.18
3.6
4.1
mmol/l
1.2
1.2
6.13
2551
28032
(3019069) Monocytes/100 leukocytes in Blood
1623
18567
0.82
10.07
4.5
5.7
%
8.9
9.0
1.17
1431
16915
(3028026) IgM [Mass/volume] in Serum or Plasma
107
1992
0.53
10.00
1.4
1.8
g/l
1.5
1.5
0.05
84
1740
(3022096) Basophils/100 leukocytes in Blood
1572
18019
0.82
9.90
4.3
5.4
%
0.6
0.6
0.65
1380
16408
(3018010) Neutrophils/100 leukocytes in Blood
1620
18494
0.82
9.75
4.5
5.4
%
60.3
60.0
0.43
1430
16825
(3002030) Lymphocytes/100 leukocytes in Blood
1656
18860
0.82
9.72
4.6
5.6
%
24.4
24.6
0.28
1442
17052
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
385
5284
0.71
9.68
4.3
4.8
%
34.8
34.4
0.26
239
3245
(36304419) Bacteria [Presence] in Urine
1481
12696
1.23
9.58
3.3
3.5
—
—
—
0
0
(3013512) EKG study
1191
13991
0.81
9.41
4.3
4.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
263
3827
0.67
9.09
1.1
1.3
titre
497.5
528.9
0.13
55
885
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3206
34267
0.84
9.01
4.0
4.7
mmol/l
4.3
4.3
0.12
2784
30097
(3009542) Hematocrit [Volume Fraction] of Blood
3382
31426
1.20
8.94
20.7
21.8
%
36.1
36.8
1.81
1769
17399
(3002179) Metamyelocytes/100 leukocytes in Blood
207
3099
0.65
8.25
2.6
3.5
%
0.5
0.6
0.46
41
749
(3005719) IgG [Mass/volume] in Serum or Plasma
156
2486
0.61
8.24
2.2
2.6
g/l
10.7
10.9
0.15
133
2209
(3000492) Spirometry study
159
2520
0.62
8.20
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
476
3629
1.34
7.94
1.8
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1221
14093
0.82
7.81
4.0
5.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1587
13918
1.19
7.79
2.3
2.4
mg/l
3.1
3.3
1.44
1297
11600
(3025159) Blasts/100 leukocytes in Blood
204
3025
0.66
7.77
2.6
3.6
%
1.9
0.2
0.42
46
830
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
30
95
3.16
7.76
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
53
1138
0.46
7.66
1.5
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1218
14038
0.83
7.64
2.2
2.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
29
93
3.12
7.36
1.1
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
27
83
3.26
7.34
1.8
1.2
nmol/l
87.8
134.4
0.78
21
58
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
205
1365
1.52
7.33
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
205
1365
1.52
7.33
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
29
94
3.09
7.24
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
40
155
2.59
7.22
1.0
1.1
nmol/l
129.9
140.8
0.82
40
155
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
30
100
3.00
7.15
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
398
5187
0.75
7.15
1.4
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
121
719
1.69
6.96
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
708
8549
0.80
6.93
1.2
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
37
141
2.63
6.92
3.6
2.7
umol/l
27.4
28.9
0.33
29
99
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
75
1382
0.54
6.88
1.7
1.6
titre
62.5
239.2
—
8
75
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
103
2.92
6.80
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
42
172
2.45
6.79
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
45
970
0.46
6.62
1.4
1.5
g/l
28.3
30.2
0.52
38
843
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
181
2.38
6.56
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
268
1923
1.41
6.55
1.2
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
353
4615
0.75
6.48
3.2
5.5
mmol/l
11.3
12.4
1.93
320
4275
(3018095) Leukocytes [#/volume] in Urine
1833
16472
1.17
6.45
3.9
4.1
e6/l
162.2
140.9
0.26
1302
12166
(4010399)
183
2654
0.68
6.27
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1501
13324
1.17
6.11
3.3
3.5
e6/l
0.5
0.6
1.16
1181
10311
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
101
1657
0.60
6.10
2.6
3.9
u/ml
69.6
105.1
0.90
96
1571
(3005322) IgE [Units/volume] in Serum or Plasma
82
1419
0.57
6.08
1.1
1.2
u/ml
247.5
241.0
0.03
67
1271
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
44
3.86
5.96
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
44
917
0.47
5.94
1.2
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
41
874
0.46
5.90
2.5
3.8
%
1.6
1.4
0.09
29
643
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
956
8188
1.20
5.88
2.9
3.1
e6/l
1.5
1.4
0.15
557
4780
(3003458) Phosphate [Moles/volume] in Serum or Plasma
530
6493
0.79
5.86
3.0
4.7
mmol/l
1.0
1.0
3.20
454
5823
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3391
35604
0.87
5.85
4.7
5.3
mmol/l
2.4
2.5
1.22
2958
31127
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
913
10578
0.83
5.82
2.1
2.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
32
745
0.43
5.81
1.4
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
228
1643
1.40
5.50
2.7
3.7
mmol/l
3.9
3.9
0.51
212
1511
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
914
0.50
5.44
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
150
1000
1.51
5.44
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
636
5281
1.23
5.36
2.5
2.5
ug/l
5.5
5.9
0.29
466
4289
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
115
1769
0.64
5.31
1.9
2.7
u/ml
373.6
3854.1
1.38
87
1482
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3239
34002
0.88
5.18
17.3
19.2
ml/min/173m2
69.2
66.1
15.26
2630
28237
(3044889) 12 lead EKG panel
2907
27302
1.13
4.97
4.8
4.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
259
3404
0.75
4.96
2.4
3.7
kpa
5.1
5.2
0.28
224
3063
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
293
0.27
4.91
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
46
881
0.52
4.90
1.3
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
786
0.49
4.85
1.3
1.4
e6/l
23560.2
66391.5
2.24
26
474
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
122
1813
0.66
4.81
2.3
2.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
686
0.46
4.76
1.4
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
260
1962
1.34
4.75
1.4
1.5
%
1.6
1.7
0.73
216
1567
(3042631) Mycobacterium sp identified in Specimen
38
765
0.49
4.73
2.2
2.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
657
7706
0.83
4.72
2.0
2.4
g/l
2.2
2.2
0.91
571
6943
(3023199) Leukocytes [#/volume] in Pleural fluid
45
855
0.52
4.69
1.3
1.4
e6/l
1264.1
1981.3
1.17
31
626
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
269
0.26
4.68
2.0
3.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
138
1990
0.68
4.66
2.2
2.9
mg/l
56.2
62.6
0.14
110
1630
(3009343) pH of Capillary blood
258
3358
0.75
4.63
2.4
3.7
ph
7.4
7.4
0.38
47
412
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
164
1153
1.43
4.60
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
146
2.26
4.60
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
139
1994
0.69
4.57
2.2
2.9
mg/l
55.0
88.8
0.59
111
1630
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
178
2444
0.72
4.55
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
615
7230
0.83
4.53
3.5
4.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
165
1166
1.42
4.51
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
173
2381
0.72
4.50
2.5
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
165
1168
1.42
4.47
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
430
0.35
4.46
1.4
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
87
2.64
4.46
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
250
3247
0.76
4.43
2.4
3.7
mmol/l
1.8
2.1
0.64
165
2354
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1674
18196
0.88
4.38
2.7
3.4
ng/l
2018.0
2276.7
1.19
1407
15762
(3013115) Eosinophils [#/volume] in Blood
1863
20113
0.88
4.36
4.2
5.2
e9/l
0.2
0.2
0.57
1551
17009
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
624
7301
0.83
4.36
2.1
2.5
%
20.3
20.4
0.03
454
6025
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3350
31886
1.13
4.28
4.9
7.2
u/l
81.4
83.3
0.84
3035
29432
(40768806) Pleura Pathology biopsy report
38
736
0.51
4.24
1.3
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
17
56
3.04
4.21
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
33
152
2.17
4.21
1.0
1.1
mg/l
29.3
46.1
3.15
26
122
(3014271) Vancomycin [Susceptibility]
79
485
1.63
4.18
2.9
3.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
138
1943
0.70
4.13
2.2
2.9
ratio
1.4
3.1
—
7
144
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
608
0.47
4.11
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
493
4103
1.22
4.09
1.5
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
215
0.23
4.08
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
13
380
0.34
4.06
1.2
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
59
991
0.59
4.04
1.8
2.4
mg/l
1.7
1.9
0.68
54
846
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
31
142
2.18
4.02
1.0
1.1
mg/l
227.0
308.5
2.55
24
119
(3006315) Basophils [#/volume] in Blood
1810
19505
0.89
4.02
4.0
5.0
e9/l
0.0
0.0
2.25
1487
16318
(3020891) Body temperature
276
2161
1.29
3.92
3.1
4.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
177
1300
1.37
3.91
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
34
661
0.51
3.88
1.5
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
99
1463
0.67
3.86
2.2
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1800
19371
0.89
3.86
4.0
5.0
e9/l
0.6
0.6
8.93
1471
16178
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
31
619
0.50
3.84
1.3
1.5
pmol/l
145.8
280.4
2.48
31
590
(4027681)
23
95
2.42
3.77
1.2
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
17
60
2.83
3.77
1.1
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
120
829
1.45
3.77
1.5
2.1
umol/l
27.0
32.8
1.39
87
651
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
18
437
0.41
3.76
1.5
3.8
u/ml
27.0
45.6
0.80
18
421
(40760888) Immunoglobulin light chains.free panel - Serum
102
1489
0.68
3.75
2.3
2.9
—
—
—
0
0
(4281824)
17
422
0.40
3.74
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
213
2758
0.76
3.73
1.5
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
393
4730
0.82
3.70
1.7
2.4
g/l
65.6
65.6
0.03
314
4093
(3022145) Colonoscopy Study observation
319
3921
0.80
3.66
1.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
101
1464
0.68
3.59
2.0
3.1
mmol/l
24.3
25.0
1.04
93
1257
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
92
1355
0.67
3.56
1.4
1.6
u/l
35.4
38.0
0.63
73
1118
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
51
2.94
3.55
1.0
1.2
%
4.6
53.2
—
5
18
(3019198) Lymphocytes [#/volume] in Blood
1853
19838
0.90
3.54
4.3
5.2
e9/l
1.7
1.9
4.92
1538
16849
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
42
743
0.56
3.54
1.2
1.2
u/ml
8.8
5.6
—
7
119
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
353
0.37
3.52
1.3
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2783
26375
1.11
3.49
4.1
4.7
mmol/l
6.9
7.0
0.46
2589
24762
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
227
2885
0.78
3.47
1.3
1.6
g/l
1.6
1.5
0.23
176
2420
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
226
2873
0.78
3.46
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
100
1441
0.69
3.46
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
48
813
0.59
3.45
1.2
1.2
u/l
38.9
45.8
0.20
36
687
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
541
0.50
3.42
2.9
3.6
%
49.8
60.8
0.98
17
322
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
258
0.35
3.41
1.1
1.2
—
116.0
—
0
10
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
42
734
0.57
3.40
1.2
1.2
u/ml
1.5
4.4
—
6
75
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
60
364
1.65
3.39
2.7
2.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
27
127
2.13
3.33
2.4
2.0
umol/l
59.0
54.3
0.35
21
88
(3023419) Bacteria identified in Sputum by Culture
33
614
0.53
3.32
1.6
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
171
2240
0.75
3.30
1.9
2.3
g/l
3.8
3.8
0.05
120
1501
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
256
0.35
3.27
1.4
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1113
10059
1.13
3.26
4.2
4.5
ng/l
169.6
413.8
2.01
1002
9032
(3017143) Hepatitis C virus Ab [Presence] in Serum
180
2337
0.76
3.26
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3017
28771
1.10
3.24
22.0
24.0
%
13.9
14.1
13.36
2900
27941
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
185
0.27
3.24
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
172
2244
0.76
3.23
1.9
2.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
896
0.62
3.22
1.4
1.5
iu/ml
0.6
13.8
1.18
21
243
(3037756) Immunofixation for Serum or Plasma
89
1291
0.68
3.22
1.2
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
607
0.54
3.21
1.2
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
71
1075
0.65
3.19
1.2
1.2
u/ml
0.8
0.9
—
8
115
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
49
2.86
3.17
1.1
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
173
2249
0.76
3.17
1.9
2.3
g/l
7.3
7.6
1.00
123
1553
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
77
1143
0.67
3.14
1.9
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
62
962
0.64
3.13
2.0
2.8
u/ml
24.6
920.1
2.19
55
870
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
29
144
2.01
3.13
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
481
5587
0.85
3.10
1.3
1.5
g/l
2.5
2.8
2.34
207
2977
(3002582) Erythrocytes [#/volume] in Urine
1586
14667
1.11
3.10
3.5
3.6
e6/l
194.3
113.9
0.49
1231
11461
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
23
468
0.49
3.08
1.7
1.9
u/ml
7.6
975.0
0.92
23
458
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
162
2115
0.76
3.07
2.1
2.4
u/ml
0.4
0.4
0.35
86
1232
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
52
836
0.62
3.07
1.5
1.7
mg/l
13.6
13.2
0.08
47
748
(1761482) Bacteria [#/volume] in Urine by Culture
133
1786
0.74
3.06
5.6
5.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
62
956
0.64
3.05
2.4
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
63
967
0.65
3.04
2.4
2.5
mmol/l
106.9
105.4
1.66
63
959
(3041354) Potassium [Moles/volume] in Venous blood
63
967
0.65
3.04
2.4
2.5
mmol/l
4.1
4.1
0.05
63
959
(40768443) Skin Pathology biopsy report
141
1874
0.74
3.03
1.1
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
48
784
0.61
3.03
1.2
1.2
u/ml
4.5
44.5
—
6
43
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
45
2.89
3.01
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
24
476
0.50
2.99
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
865
7737
1.14
2.98
3.1
3.3
e6/l
2.8
2.7
0.09
484
4372
(3004588) Protein electrophoresis panel - Serum or Plasma
334
3993
0.82
2.98
1.8
2.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
394
0.45
2.97
1.9
2.2
ml
556.1
629.3
—
8
239
(3008152) Bicarbonate [Moles/volume] in Arterial blood
407
3437
1.20
2.96
4.3
5.9
mmol/l
24.7
24.5
0.37
378
3220
(3000330) Specific gravity of Urine by Test strip
228
2834
0.79
2.94
4.4
4.5
—
—
—
0
0
(4094501)
52
824
0.63
2.91
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
240
0.37
2.90
1.4
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
225
0.35
2.90
1.1
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
225
0.35
2.90
1.1
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
225
0.35
2.90
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
46
2.82
2.90
1.9
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1547
16566
0.90
2.83
8.6
10.7
e9/l
0.0
0.0
2.10
1233
13307
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
65
974
0.66
2.82
2.0
2.1
g/l
3.7
3.6
0.08
58
911
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
190
0.31
2.78
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
42
692
0.60
2.78
1.5
2.0
pg
32.1
32.4
0.25
42
683
(3013650) Neutrophils [#/volume] in Blood by Automated count
2165
22801
0.91
2.78
5.4
7.8
e9/l
4.5
4.5
0.02
1826
19459
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1478
13687
1.11
2.77
2.2
2.5
u/l
57.4
59.6
0.74
1330
12443
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
299
0.40
2.75
1.3
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
298
0.40
2.74
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
457
5272
0.85
2.73
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1147
10490
1.12
2.72
2.7
2.8
e6/l
5.9
5.3
0.54
1003
9173
(46235355) HIV 1 and 2 tests - Meaningful Use set
216
2674
0.80
2.71
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
567
6432
0.87
2.71
1.7
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1017
11109
0.89
2.69
2.2
2.9
u/l
37.5
36.7
0.09
917
10322
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
34
189
1.80
2.68
1.2
1.1
—
—
—
0
0
(4034850)
169
1312
1.29
2.67
10.5
13.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
167
2122
0.78
2.62
1.9
2.2
g/l
10.2
10.4
0.25
125
1699
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
60
897
0.66
2.60
1.9
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
51
788
0.64
2.59
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
34
578
0.58
2.57
3.1
3.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
25
3.60
2.56
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
87
2.18
2.55
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
225
0.40
2.54
1.1
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
228
2781
0.81
2.52
1.2
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
158
2004
0.78
2.47
2.7
4.2
mmol/l
25.1
24.9
0.45
130
1767
(3022948) Iron [Moles/volume] in Serum or Plasma
753
8317
0.89
2.41
2.0
2.4
umol/l
11.3
11.3
0.04
652
7468
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
34
2.94
2.40
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
346
0.49
2.36
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
437
0.55
2.35
1.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
25
447
0.56
2.31
1.0
1.2
—
18.9
—
0
7
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3976
38691
1.09
2.29
8.9
11.2
u/l
21.2
22.9
2.25
3678
36558
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
35
2.85
2.29
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
432
0.55
2.27
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
199
2431
0.81
2.26
1.6
1.8
ug/l
1.6
2.6
1.24
155
2015
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
60
0.00
2.24
0.0
2.9
—
42.8
—
0
24
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
221
2667
0.82
2.23
4.3
6.9
mmol/l
24.3
24.4
0.15
197
2411
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
452
0.57
2.19
1.1
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
96
1275
0.75
2.15
2.1
2.9
kpa
7.8
7.6
0.31
90
1172
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
397
0.55
2.12
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
82
1105
0.74
2.05
2.1
2.8
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
301
0.50
2.04
1.0
1.1
—
1.7
—
0
11
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
174
0.40
2.02
1.1
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
174
0.40
2.02
1.1
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
24
416
0.57
2.02
1.0
1.3
pmol/l
191.1
249.7
1.26
17
312
(3025130) Human papilloma virus identified in Specimen
6
162
0.37
2.00
1.3
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
351
0.54
2.00
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
167
2047
0.81
2.00
1.9
2.3
g/l
3.2
3.2
0.08
122
1530
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
574
0.64
1.99
2.8
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
1080
10002
1.10
1.98
4.4
6.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
633
0.66
1.97
1.1
1.4
nmol/l
0.6
0.8
2.12
33
502
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
297
0.50
1.97
2.9
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
927
8527
1.10
1.96
34.4
33.2
inr
1.5
1.6
0.18
64
1087
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
234
2765
0.84
1.93
3.4
5.7
mmol/l
24.6
25.0
0.74
228
2730
(3019225) pH of Specimen
461
5169
0.88
1.91
3.9
4.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
157
0.38
1.88
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
553
0.65
1.87
1.2
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
65
2.15
1.86
1.3
1.1
miu/ml
1528.6
1665.2
0.14
14
65
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
53
0.00
1.86
0.0
1.2
—
7.3
—
0
39
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
15
72
2.08
1.85
1.1
1.3
ug/l
74.2
99.6
—
10
48
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
287
2464
1.17
1.83
2.1
3.2
mmol/l
24.6
24.1
1.41
252
2187
(3008898) HLA-B27 [Presence]
29
464
0.62
1.81
1.1
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
684
7470
0.90
1.80
1.9
2.6
mmol/l
0.8
0.8
1.53
612
6747
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
105
1338
0.78
1.79
1.5
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
59
815
0.72
1.76
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
259
0.50
1.76
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
47
2.34
1.76
2.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
131
1.75
1.76
1.1
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
56
778
0.72
1.74
2.7
3.2
%
59.4
60.2
0.17
56
778
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
397
0.60
1.73
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
36
2.50
1.73
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1530
14457
1.08
1.73
4.5
5.7
ug/l
7.2
5.2
0.23
1292
12562
(3000494) Fungus identified in Specimen by Culture
365
4125
0.87
1.72
1.2
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
117
1463
0.79
1.72
1.1
1.1
iu/ml
76.2
115.2
0.81
39
459
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
504
0.65
1.70
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
26
419
0.62
1.69
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
258
2212
1.17
1.69
1.2
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
48
0.00
1.69
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
178
0.45
1.68
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
26
418
0.62
1.68
1.2
1.3
nmol/l
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
204
2405
0.84
1.68
1.8
2.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
356
0.59
1.68
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
191
2263
0.84
1.66
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
162
0.43
1.66
1.9
2.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
23
134
1.72
1.64
1.2
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
378
0.61
1.63
1.0
1.3
u/ml
114.3
125.2
—
7
78
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
251
0.52
1.62
2.8
1.9
—
69.0
—
0
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
32
486
0.65
1.61
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
314
0.57
1.61
1.1
1.5
%
8.5
10.2
0.76
18
314
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
428
3820
1.13
1.60
1.9
2.3
u/l
31.5
36.3
1.69
346
3207
(21494755) Public health laboratory ask at order entry panel
15
274
0.54
1.58
1.2
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
24
144
1.67
1.56
1.4
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
65
863
0.75
1.54
1.5
1.4
g/l
0.2
0.2
0.27
60
805
(3008116) Ketones [Moles/volume] in Urine by Test strip
17
92
1.85
1.54
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
35
516
0.67
1.54
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
44
621
0.70
1.53
1.3
1.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
1.2
—
10.2
—
0
42
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
21
2.85
1.50
1.7
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
417
0.64
1.49
1.1
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
45
0.00
1.49
0.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
19
108
1.76
1.49
1.1
1.1
u/l
1.0
1.2
—
10
60
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
306
0.59
1.48
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
355
0.62
1.48
4.7
14.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
65
2.00
1.47
1.9
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
37
2.43
1.47
1.1
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
132
1597
0.82
1.47
2.1
2.3
g/l
0.0
0.1
0.31
113
1409
(3023520) Reticulocytes [#/volume] in Blood
471
5184
0.90
1.47
1.9
2.3
e9/l
64.0
67.0
1.00
366
3960
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
8
169
0.47
1.46
1.4
1.8
e9/l
0.3
0.2
—
8
150
(3017732) Neutrophils [#/volume] in Blood
214
2478
0.86
1.45
3.4
3.4
e9/l
4.0
4.4
1.31
131
1625
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
67
876
0.76
1.45
1.9
2.0
%
100.1
86.6
6.53
62
831
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1224
11544
1.07
1.44
4.4
5.0
%
21.7
22.4
0.90
621
6335
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
191
2226
0.85
1.42
1.8
1.9
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
276
0.58
1.40
2.8
1.8
e9/l
1.1
1.0
—
10
173
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
31
456
0.68
1.38
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
147
1746
0.84
1.37
2.6
2.7
g/l
0.3
0.3
0.11
42
633
(3044007) Cell count panel - Peritoneal fluid
5
122
0.41
1.36
1.4
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
123
0.41
1.36
1.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
371
0.64
1.36
1.3
1.4
—
—
—
0
0
(3019977) pH of Arterial blood
22
346
0.63
1.35
3.6
2.0
ph
7.4
7.4
—
5
129
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
28
417
0.67
1.33
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
146
1223
1.20
1.32
1.3
1.4
ug/g
246.2
267.2
0.62
78
756
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
207
0.53
1.31
3.3
1.8
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
26
391
0.66
1.30
2.5
3.1
mg/l
31.0
34.9
0.06
20
295
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
123
1477
0.83
1.30
2.1
2.3
g/l
0.0
0.0
0.00
106
1318
(3020191) Ethanol [Moles/volume] in Serum or Plasma
28
184
1.52
1.30
1.2
1.2
promille
0.8
1.0
0.42
19
142
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
63
816
0.77
1.30
2.7
2.1
%
222.1
213.2
0.29
55
765
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
58
437
1.33
1.29
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
76
1.84
1.28
1.9
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
76
1.84
1.28
1.9
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
76
1.84
1.28
1.9
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
137
1.60
1.28
1.5
1.4
umol/l
54.9
94.5
1.53
13
83
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
388
0.67
1.26
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
126
1504
0.83
1.26
2.1
2.3
g/l
0.0
0.0
0.79
107
1324
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
57
430
1.33
1.26
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
231
2018
1.15
1.25
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
74
934
0.79
1.25
1.5
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
77
1.82
1.24
1.9
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
52
686
0.75
1.24
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
40
548
0.73
1.22
1.5
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
325
0.64
1.22
1.1
1.3
u/l
7.0
11.8
1.54
15
248
(3013707) Erythrocyte sedimentation rate by Westergren method
2998
29191
1.06
1.20
3.7
4.3
mm/h
14.3
16.6
11.78
2643
26224
(3033799) Differential panel - Peritoneal fluid
7
145
0.48
1.19
2.3
1.8
—
—
—
0
0
(4015189)
7
145
0.48
1.19
1.3
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
229
2589
0.88
1.17
4.6
7.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
611
0.75
1.16
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
284
0.63
1.15
1.1
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
157
1819
0.86
1.13
2.0
2.0
nmol/l
10.9
10.6
0.19
140
1514
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
742
0.78
1.12
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
64
806
0.79
1.10
1.4
1.4
—
—
—
0
0
(4146454)
40
536
0.74
1.09
2.2
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
385
0.70
1.07
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
557
0.75
1.07
2.8
3.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
44
579
0.76
1.06
1.2
1.3
—
—
—
0
0
(44806420)
14
228
0.61
1.04
2.7
2.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
21
312
0.67
1.04
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
359
0.69
1.04
1.1
1.1
u/ml
301.5
305.7
0.02
15
205
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
300
0.66
1.04
1.0
1.1
—
—
—
0
0
(44790048)
54
419
1.29
1.02
1.3
1.3
—
—
—
0
0
(44790047)
54
419
1.29
1.02
1.3
1.3
—
—
—
0
0
(44790049)
54
419
1.29
1.02
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
163
1865
0.87
1.02
2.0
2.4
g/l
1.2
1.2
0.08
120
1508
(3024354) Oxygen [Partial pressure] in Venous blood
480
4430
1.09
1.02
2.2
2.9
kpa
4.2
4.3
0.31
456
4251
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
106
1.60
1.01
1.1
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
268
2968
0.90
1.01
2.4
3.3
mmol/l
25.4
25.1
0.80
258
2883
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
108
0.46
1.00
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
424
0.73
0.98
1.0
1.2
u/l
67.9
61.4
0.22
17
274
(3043410) Blood group antigens tested for on Red Blood Cells
7
132
0.53
0.98
1.0
2.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
47
603
0.78
0.97
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
31
0.00
0.96
0.0
4.9
—
—
—
0
0
(3026782) Osmolality of Urine
1072
10207
1.06
0.96
2.9
3.1
mosm/kgh2o
569.2
537.3
5.66
900
8629
(3025468) Yersinia sp identified in Specimen by Organism specific culture
46
590
0.78
0.95
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
46
590
0.78
0.95
1.2
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
257
0.66
0.93
1.6
1.5
u/l
7.0
8.2
—
8
114
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
16
245
0.65
0.93
1.1
1.2
u/l
76.1
100.6
0.90
16
205
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
46
588
0.78
0.93
1.2
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
66
533
1.24
0.93
1.2
1.3
nmol/l
378.7
304.8
1.54
47
402
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
55
687
0.80
0.92
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
94
1111
0.84
0.91
1.2
1.3
mmol/l
69.5
60.2
1.51
80
871
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
10
55
1.82
0.91
1.1
1.4
umol/l
3.3
2.2
—
10
49
(3019060) Gas panel - Arterial blood
398
3667
1.09
0.90
2.8
4.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
42
541
0.77
0.90
1.5
1.4
%
68.2
64.7
0.29
27
350
(44806118)
53
419
1.26
0.90
1.3
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
35
261
1.34
0.90
1.1
1.2
—
786.7
—
0
6
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
679
6390
1.07
0.89
1.2
1.2
u/ml
1.0
1.5
1.54
145
1488
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
47
595
0.79
0.89
1.2
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
489
4549
1.08
0.88
3.1
5.1
mmol/l
1.5
1.4
0.90
474
4319
(3020961) Endomysium IgA Ab [Titer] in Serum
137
1190
1.15
0.88
1.1
1.1
titre
415.0
165.7
—
5
16
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
93
1094
0.85
0.87
1.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
20
287
0.69
0.86
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
20
287
0.69
0.86
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
51
633
0.80
0.83
1.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
588
0.80
0.82
1.2
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
189
0.63
0.81
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
25
340
0.73
0.80
1.2
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
81
1.60
0.80
1.0
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
24
0.00
0.79
0.0
1.7
—
0.3
—
0
6
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
3.4
—
0
6
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
187
0.64
0.78
1.7
1.9
e6/l
720.8
619.7
—
5
76
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
2.6
—
6.0
—
0
21
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3036489) Thrombin time
107
1231
0.86
0.78
1.8
1.7
s
21.7
21.9
0.05
95
1132
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
96
0.52
0.78
6.2
3.4
—
36.0
—
0
10
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
40
506
0.79
0.78
1.4
1.6
u/ml
35.1
26.6
—
8
115
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
124
0.56
0.77
1.0
2.0
—
94777.2
—
0
19
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
0
27
0.00
0.77
0.0
1.3
—
0.6
—
0
14
(3002173) Hemoglobin [Mass/volume] in Arterial blood
513
4811
1.07
0.77
3.6
6.1
g/l
119.6
118.3
0.78
493
4638
(3032080) INR in Blood by Coagulation assay
2044
20911
0.96
0.76
9.3
12.2
inr
1.3
1.4
2.17
502
5448
(40758292) HTLV I+II Ab panel - Serum
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
107
1227
0.87
0.75
2.7
3.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
156
1744
0.89
0.75
2.0
2.2
g/l
37.1
36.5
0.55
118
1394
(4211845)
18
255
0.70
0.75
5.4
4.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3420
34623
0.96
0.74
6.2
6.9
mmol/mol
41.9
41.7
0.47
3013
30672
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
24
2.08
0.74
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
134
0.60
0.73
1.8
2.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
109
1244
0.87
0.72
2.0
2.3
g/l
126.2
124.3
0.47
95
917
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
770
8047
0.95
0.72
2.9
3.4
ug/l
0.7
0.9
5.10
543
5924
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
108
0.55
0.72
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
55
664
0.82
0.72
1.2
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
61
729
0.83
0.72
2.2
2.2
mg/l
24.1
27.8
0.20
17
175
(3004451) EKG impression Narrative
22
298
0.74
0.71
1.2
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
68
1.62
0.71
3.7
3.0
u/field
0.3
0.5
0.68
11
68
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
90
1039
0.86
0.71
1.2
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
50
407
1.23
0.70
1.1
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
208
2277
0.91
0.69
3.1
4.3
%
0.9
0.9
0.91
194
2146
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
101
1.48
0.69
1.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
19
261
0.73
0.68
1.1
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
265
2863
0.92
0.67
2.5
2.6
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
20
144
1.39
0.67
1.1
1.2
%
70.0
67.6
0.13
13
119
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
93
0.54
0.66
1.4
1.5
ng/l
155.4
122.7
—
5
93
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3549
35862
0.96
0.66
4.7
5.3
mmol/l
6.1
6.2
0.23
3016
31021
(3017569) Oxygen content in Arterial blood
21
282
0.74
0.65
3.0
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
55
656
0.83
0.65
1.3
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
201
0.69
0.64
1.1
1.2
mmol/l
12.7
11.6
—
8
66
(3006462) Nitrate [Presence] in Urine
17
235
0.72
0.64
5.7
4.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
636
6049
1.06
0.63
3.5
5.5
kpa
11.4
11.6
0.23
593
5670
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
109
1229
0.88
0.63
1.2
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
66
772
0.85
0.63
2.4
2.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
47
567
0.83
0.63
1.4
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
636
6051
1.06
0.63
3.5
5.6
kpa
4.9
5.0
1.99
593
5676
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
212
2304
0.91
0.63
3.2
4.3
%
1.5
1.5
0.08
196
2174
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
43
522
0.82
0.62
2.7
3.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
31
390
0.79
0.61
1.6
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
24
312
0.77
0.61
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
29
367
0.79
0.60
1.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
29
367
0.79
0.60
1.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
29
367
0.79
0.60
1.2
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2256
22950
0.97
0.60
3.4
5.5
umol/l
12.7
12.6
0.12
2037
21517
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
141
1558
0.90
0.59
3.1
3.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
22
0.00
0.59
0.0
5.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
148
1.35
0.59
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
59
689
0.85
0.57
1.2
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
87
986
0.88
0.56
1.3
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
36
1.66
0.56
1.8
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
396
0.81
0.56
1.2
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
554
5278
1.05
0.54
1.6
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
82
1.46
0.53
1.9
2.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
28
222
1.26
0.53
1.5
1.7
mmol/l
8.8
9.4
0.74
22
179
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
840
8678
0.96
0.52
1.5
1.6
mg/l
1.9
1.6
0.80
629
6807
(3000285) Sodium [Moles/volume] in Blood
13
91
1.43
0.52
1.5
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
6
96
0.62
0.52
1.2
1.0
—
2.2
—
0
9
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
6
96
0.62
0.52
1.8
1.3
mg/l
0.8
53.1
—
6
75
(40762365) Oxygen content in Arterial blood by calculation
6
99
0.60
0.51
1.2
2.3
ml/dl
15.4
14.5
—
6
89
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
132
0.68
0.51
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
132
0.68
0.51
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
300
3183
0.94
0.51
2.5
3.0
ml/min/173m2
57.9
55.4
0.70
131
1521
(3035320) C reactive protein [Mass/volume] in Body fluid
38
314
1.21
0.50
2.9
2.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
25
197
1.27
0.50
1.0
1.1
%
91.9
91.1
0.07
19
185
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
46
388
1.18
0.50
1.1
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
235
0.76
0.50
1.8
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
212
0.75
0.49
1.1
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
110
1.36
0.48
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
76
1.44
0.47
2.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
36
299
1.20
0.46
1.7
2.7
mmol/l
7.6
7.2
0.23
27
198
(3047181) Lactate [Moles/volume] in Blood
169
1559
1.08
0.46
3.1
5.2
mmol/l
1.4
1.4
0.03
145
1392
(3016502) Oxygen saturation in Arterial blood
562
5386
1.05
0.45
3.5
5.7
%
95.6
95.1
1.04
536
5147
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
81
0.62
0.45
1.6
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
119
0.67
0.45
4.1
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
140
1282
1.09
0.45
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
175
0.74
0.45
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
175
0.74
0.45
1.1
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
121
1102
1.10
0.44
3.2
5.7
mmol/l
105.2
104.6
0.67
107
985
(3039000) Anion gap in Blood
121
1102
1.10
0.44
3.2
5.7
mmol/l
10.7
11.2
0.81
107
985
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
34
404
0.84
0.43
1.6
1.4
%
14.9
25.4
3.05
23
255
(3051387) C reactive protein [Mass/volume] in Capillary blood
106
1161
0.91
0.42
4.7
3.9
mg/l
32.3
30.8
0.15
75
780
(3025577) Chromium [Mass/volume] in Blood
26
315
0.82
0.41
1.8
2.0
ug/l
1.4
2.0
1.43
21
262
(3045414) Leukocytes [Presence] in Urine
163
1748
0.93
0.41
2.0
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
62
698
0.88
0.41
1.2
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
138
0.72
0.40
1.1
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
59
1.35
0.40
12.4
10.2
%
13.5
14.0
—
8
59
(4268621)
15
194
0.77
0.40
1.8
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
411
4283
0.95
0.40
3.4
6.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
78.8
—
0
7
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
240.9
—
0
17
(40758358) Immune stain study
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
629
6066
1.04
0.40
3.5
5.5
mmol/l
1.2
1.2
0.05
474
4603
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
399
0.85
0.39
1.7
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
19
0.00
0.39
0.0
3.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
136
0.73
0.38
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
136
0.73
0.38
1.2
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
80
1.37
0.38
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
67
1.34
0.38
1.2
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
21
257
0.81
0.37
1.1
1.1
u/ml
4.7
3.2
—
5
52
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
439
4211
1.04
0.37
2.9
3.7
mmol/l
1.2
1.2
0.91
340
3602
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
37
1.35
0.37
3.2
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
661
6395
1.04
0.36
3.8
5.6
mmol/l
104.6
104.1
1.56
638
6226
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
198
1861
1.06
0.36
2.3
2.9
pmol/l
4.2
4.3
0.15
163
1546
(3008295) Osmolality of Serum or Plasma
42
480
0.87
0.36
1.4
1.3
mosm/kgh2o
277.6
274.1
0.36
27
332
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
79
0.63
0.35
1.2
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
145
0.76
0.35
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
31
264
1.17
0.34
1.1
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
11
82
1.34
0.33
2.1
2.2
—
—
—
0
0
(4306422)
30
255
1.17
0.33
1.4
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
25
209
1.19
0.33
1.1
1.2
—
2.8
—
0
9
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
87
0.69
0.33
1.2
1.0
—
0.1
—
0
20
(3048879) Bone marrow aspiration report
14
176
0.79
0.32
1.2
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
47
1.27
0.32
1.3
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
548
5303
1.03
0.31
2.3
3.3
kpa
5.9
5.8
0.88
522
5108
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
29
248
1.17
0.31
1.0
1.1
%
115.0
114.2
0.05
22
220
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
96
0.73
0.30
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
98
0.71
0.30
1.0
1.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
737
7539
0.97
0.30
1.6
1.8
s
29.2
30.2
5.02
714
7258
(3041096) Erythrocytes [Presence] in Urine by Automated
1056
10326
1.03
0.30
4.3
4.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
345
3314
1.04
0.29
1.7
1.8
ug/g
159.5
178.8
0.51
254
2503
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
39
440
0.88
0.29
1.6
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
63
571
1.10
0.29
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
111
1187
0.93
0.29
1.1
1.1
—
1.4
—
0
19
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
69
629
1.10
0.29
1.7
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
108
0.74
0.29
4.1
1.7
—
—
—
0
0
(4212803)
7
57
1.23
0.28
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1033
10506
0.98
0.28
3.4
3.9
%
78.7
80.7
1.66
999
10223
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
274
2623
1.04
0.28
2.0
2.4
%
0.7
0.7
1.30
262
2520
(3051101) Glucose [Moles/volume] in Cord blood
9
118
0.76
0.27
6.0
5.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
17
140
1.21
0.27
1.1
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
160
0.81
0.26
1.9
2.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
326
3369
0.96
0.26
1.5
2.0
nmol/l
392.7
389.5
0.11
279
2966
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
28
243
1.15
0.26
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
71
0.70
0.26
1.4
1.5
ug/l
11.5
9.7
—
5
71
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
107
1137
0.94
0.25
1.7
2.3
ug/min
118.0
94.2
0.22
39
652
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
407
4185
0.97
0.25
2.5
3.3
ng/l
79.7
97.8
4.93
330
3392
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
263
1.14
0.25
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
169
0.83
0.24
4.1
6.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
75
695
1.08
0.23
1.5
1.6
iu/l
2.8
4.4
2.12
21
190
(3028433) Virus identified in Specimen by Culture
10
125
0.80
0.23
1.0
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
103
1091
0.94
0.23
1.3
1.5
e6/l
33389.0
17060.3
0.77
70
783
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
14
115
1.22
0.23
1.2
1.2
%
27.1
27.4
—
9
82
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
39
1.28
0.23
18.8
14.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
178
0.84
0.22
2.2
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
178
0.84
0.22
2.2
2.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
495
1.09
0.22
1.4
1.5
mg/l
2.9
3.1
0.07
43
386
(3039443) Prostate specific Ag panel - Serum or Plasma
26
294
0.88
0.22
1.5
1.7
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
41
1.22
0.22
2.2
2.8
nmol/l
112.6
144.4
—
5
32
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
3.8
—
0
11
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
104
0.77
0.21
1.8
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
4.2
—
0
13
(3027945) Reticulocytes/100 erythrocytes in Blood
680
6916
0.98
0.20
1.7
2.2
%
1.7
1.8
1.96
548
5895
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
144
0.83
0.20
1.4
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
541
5285
1.02
0.19
2.3
3.3
mmol/l
2.3
2.0
1.06
431
4233
(40761536) Microorganisms panel - Urine sediment
364
3538
1.03
0.19
4.3
4.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
183
1894
0.96
0.18
3.5
3.3
nmol/l
0.8
0.8
0.44
145
1451
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
524
5125
1.02
0.18
4.2
4.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
289
0.90
0.18
1.3
1.2
mmol/l
8.5
8.2
0.17
20
183
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
34
372
0.91
0.18
1.5
1.5
nmol/l
51.7
50.8
0.07
34
348
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
416
4244
0.98
0.17
1.6
1.9
g/l
0.2
0.2
1.33
364
3838
(3049717) Cytology report of Urine Cyto stain
219
2255
0.97
0.17
2.5
2.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
194
1873
1.03
0.16
1.8
2.1
ug/l
1926.1
590.8
0.65
181
1766
(3004119) Hemoglobin [Mass/volume] in Venous blood
335
3420
0.98
0.15
2.2
3.1
g/l
127.0
125.1
1.03
328
3335
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
275
2674
1.03
0.15
2.0
2.4
%
1.1
1.1
0.41
275
2661
(44813793)
12
139
0.86
0.14
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
26
236
1.10
0.14
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
150
1.13
0.14
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
33
304
1.08
0.14
2.6
1.6
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
9
106
0.85
0.13
1.1
1.1
—
22.3
—
0
12
(40767503) Oxygen content in Capillary blood by calculation
114
1179
0.96
0.13
2.2
2.5
%
16.2
15.4
1.79
53
599
(3026389) Candida sp identified in Specimen by Organism specific culture
53
559
0.95
0.12
1.5
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
17
189
0.90
0.12
1.4
1.5
—
7.5
—
0
8
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
14
123
1.14
0.12
1.7
1.7
nmol/l
15.1
7.2
0.29
14
102
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
46
486
0.94
0.12
1.5
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
74
707
1.04
0.11
6.2
9.7
mmol/l
7.2
7.5
0.22
56
574
(4062490)
23
250
0.92
0.11
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
291
0.93
0.11
1.7
1.7
—
—
—
0
0
(3010421) pH of Blood
135
1387
0.97
0.11
2.9
4.3
ph
7.4
7.4
0.09
115
1182
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
18
198
0.91
0.11
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
135
0.89
0.10
1.8
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
171
1667
1.02
0.10
1.3
1.3
au/ml
47.3
61.3
—
7
71
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
44
1.13
0.10
1.4
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
114
0.87
0.09
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2057
20621
0.99
0.09
2.7
3.1
u/l
46.2
57.1
7.53
1791
18210
(3027923) C peptide [Moles/volume] in Serum or Plasma
21
193
1.09
0.09
1.2
1.3
nmol/l
1.3
1.0
0.70
16
145
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
124
0.88
0.09
1.1
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
5
48
1.04
0.09
1.0
1.1
pmol/l
16.0
17.0
—
5
41
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1688
16765
1.01
0.07
2.6
2.9
ug/l
129.9
152.7
3.42
1456
14824
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
29
306
0.95
0.07
1.2
1.1
u/ml
2.0
4.0
—
8
101
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
31
293
1.06
0.07
1.2
1.1
u/ml
2.4
4.6
—
10
146
(3029075) Extractable nuclear Ab panel - Serum
7
81
0.86
0.07
1.1
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
23
244
0.94
0.07
1.2
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
30
315
0.95
0.06
1.6
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
82
840
0.97
0.06
1.5
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
105
0.85
0.06
1.4
1.6
ug/l
16.1
377.1
—
9
98
(1002224) Polysomnography panel
48
462
1.04
0.06
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
460
4625
0.99
0.05
1.9
2.4
umol/l
11.9
10.1
0.66
377
3969
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
60
615
0.97
0.05
4.3
5.7
mg/l
13.2
12.9
0.15
50
545
(3014051) Protein [Presence] in Urine by Test strip
97
985
0.98
0.04
2.3
2.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
57
556
1.02
0.03
2.5
2.4
u/field
2.1
2.2
0.04
20
165
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
111
1.08
0.03
1.4
2.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
43
439
0.98
0.02
1.1
1.3
e6/l
349055.6
191012.8
0.39
25
296
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
122
1.06
0.02
1.2
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
123
1215
1.01
0.02
2.9
4.5
mmol/l
2.0
2.9
5.24
88
826
(3024928) Oxygen saturation in Venous blood
105
1036
1.01
0.02
1.3
2.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
123
1216
1.01
0.02
2.9
4.5
kpa
5.0
5.0
0.63
115
1180
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
561
5581
1.00
0.02
2.9
3.2
ng/l
200.4
292.1
8.55
513
5094
(3027315) Oxygen [Partial pressure] in Blood
123
1218
1.01
0.01
2.9
4.5
kpa
8.1
8.2
0.33
114
1182
(3032057) Clostridioides difficile [Presence] in Stool
15
148
1.01
0.00
1.7
1.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
28
279
1.00
0.00
2.8
2.0
u/field
2.8
2.8
0.01
19
184
(3051651) Icteric interference index of Serum or Plasma
29
291
0.99
0.00
2.4
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
111
0.99
0.00
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
210
1.00
0.00
1.3
1.3
—
—
—
0
0
(4024509)
52
520
1.00
0.00
1.7
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
318
3177
1.00
0.00
3.9
3.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
12
121
0.99
0.00
1.3
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
294
1.02
0.00
1.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
294
1.02
0.00
1.1
1.3
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
59
0.85
0.00
1.2
1.0
—
0.6
—
0
26
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
85.8
—
0
5
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
95
0.95
0.00
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
7
0.00
0.00
0.0
2.0
—
131.4
—
0
7
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.2
—
369.0
—
0
6
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
0.2
—
0
8
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
6
64
0.94
0.00
1.2
1.0
—
0.6
—
0
27
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
20.2
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.4
—
0
6
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
7.1
—
63.1
—
0
7
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.3
—
0
5
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
2.6
—
0
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
57
0.88
0.00
1.2
1.0
—
0.4
—
0
22
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
59
1.01
0.00
1.0
1.8
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1798.3
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ADMED_ACHEI_RIVASTIGMINE – Use of rivastigmine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).